AB Kelonia OY
Finance · Finland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Högbergsgatan 34, Helsinki, Uusimaa, 001...Phone Number
+358 400911058Website
www.kelonia.fiRevenue
<$5 MillionIndustry
About AB Kelonia OY
Is AB Kelonia OY your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if AB Kelonia OY is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at AB Kelonia OY
Earning: See what the market has to say on AB Kelonia OY recently announced quarterly report
Funding: Get notified immidiatlly once AB Kelonia OY has new funding data
Website visits: Recent activity has been detected on your website
Click to see if AB Kelonia OY had a recent Job posting/layoffs
Check if AB Kelonia OY has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when AB Kelonia OY launches new products
AB Kelonia OY, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
AB Kelonia OY is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
AB Kelonia OY is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about AB Kelonia OY.
AB Kelonia OY Tech Stack
A closer look at the technologies used by AB Kelonia OY
AB Kelonia OY News & Media
Kelonia Therapeutics Raises $50M in Series A Financing
Kelonia Therapeutics, a Boston, MA-based biotech company focused on in vivo gene delivery, raised $50m in Series A financing. Backers included Alta Partners, Horizons Ventures, Venrock and other investors. The company will use the funding to advance genetic medicines starting with an “off-the-shelf” chimeric antigen receptor (CAR) to treat hematologic cancer that may enable the […] The post Kelonia Therapeutics Raises $50M in Series A Financing appeared first on FinSMEs.Kelonia Therapeutics Launches with $50 Million Series A Financing to Pioneer Precision Targeted Genetic Medicines
BOSTON--(BUSINESS WIRE)--Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, launched today with a $50 million Series A financing to usher in a new era of genetic medicines for a wide range of diseases. Kelonia’s platform overcomes the central challenge that has prevented the full realization of gene therapy for patients. Despite life-changing responses, existing gene therapies are highly complex, costly, and limited by complicated treatment paradigms, tractable thera
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AB Kelonia OY
Ab Kelonia Oy is an investment company owned by Finnish-Swedish public utility funds and foundations. The company's investment activities focus on venture capital investments, primarily through investment commitments in domestic investment companies or funds aimed at investing in unlisted growth companies.... Read More